K87 - OmicsDI

Show results for

Unknown (21)
Genomics (3)
Proteomics (2)
Transcriptomics (1)
Metabolomics (1)

Organisms

Alphavirus (2)
Anemia (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Clostridium perfringens (2)
Cowpox virus (2)
Cytomegalovirus (2)
Dengue virus (2)
Eukaryota (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Kamptonema sp. (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Pseudomonas aeruginosa (2)
Rattus (2)
Sarbecovirus (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Staphylococcus aureus (2)
Streptococcus pneumoniae (2)
Sus scrofa (1)

Organisms

Klebsiella quasipneumoniae subsp. similipneumoniae (1)
Sus scrofa (1)

Repository

ENA (3)
pride (2)
biostudies-arrayexpress (1)
MetaboLights (1)

Tissue

Bronchial epithelial cell (1)
Epithelial cell (1)
Lung (1)

Disease

Disease free (1)
Influenza (1)

Technology Type

Affinity purification coupled with mass spectrometry proteomics (2)
Mass Spectrometry (2)
Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2014 (1)
2026 (1)
2022 (1)
2019 (1)

Metabolite Name

N-(3-bromophenyl)-2-[4-(morpholin-4-ylcarbonyl)-2-oxohydroquinolyl]acetamide (1)
1,2,4-Triazin-5(2H)-one, 6-(1,1-dimethylethyl)-3-(methylthio)- (1)
2-Hydroxy-4-Methoxychalcone (1)
N,N-Diethyl-4-Hydroxybenzamide (1)
P-Toluenesulfonamide (1)
2-(methylethylidene)butanedioic acid (1)
2-(3-(8-hydroxyoctyl)phenoxy)-2-methylpropanoic acid (1)
2-(4-methyl-6-(2-naphthyloxy)pyrimidin-2-ylthio)-1-phenylethan-1-one (1)
PS(18:1/18:0) (1)
2-(4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1H-pyrazol-5-yl)-4-ethyl-5-methoxyphenol (1)
3,4-dimethyl-9-phenyl-7H-furo[2,3-f]chromen-7-one (1)
12-Hydroxy-6-Epi-Albrassitriol (1)
Ethyl 2-[2-(1,3,7-trimethyl-2,6-dioxo-1,3,7-trihydropurin-8-ylthio)benzimidazo lyl]acetate (1)
[4-(difluoromethoxy)-3-ethoxyphenyl]-N-(1-methylpyrazol-3-yl)carboxamide (1)
2-{4-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-enyl]phenoxy}acetamide (1)
Sissotrine (1)
Methyl 2-[(5,6,7-trimethoxy-3-oxohydroisobenzofuran-4-yl)methylthio]benzoate (1)
N-(2-chlorophenyl)-2-[2-oxo-4-(piperidylcarbonyl)hydroquinolyl]acetamide (1)
NA-135 (1)
1,3,6-Trihydroxy-2-(3-methylbut-2-enyl)xanthen-9-one (1)
7-(1,6-dihydroxy-3-methyl-5-(methylethyl)-8-{[(2-methylphenyl)amino]methylene} -7-oxo(2-naphthyl))-3,8-dihydroxy-6-methyl-4-(methylethyl)-1-{[(2-methylphenyl )amino]methylene}naphthalen-2-one (1)
Phenylmethyl 1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]pyrrolidine-2-carboxylate (1)
7-Benzofurancarboxylic acid, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-6-(2-phenylethyl)- (1)
3-ethyl-4-hydroxy-1-benzylhydroquinolin-2-one (1)
Kaurenic acid (1)
(2Z)-2-benzoxazol-2-yl-3-(4-hydroxy-3-methoxyphenyl)-1-(4-methylphenyl)prop-2- en-1-one (1)
2-[4-(N,N-diethylcarbamoyl)-2-oxohydroquinolyl]-N-(2,4-difluorophenyl)acetamid e (1)
Pantothenic acid (Not validated) (1)
2H-benzo[3,4-d]1,3-dioxolen-5-yl-N-(4,5,6,7-tetrahydrobenzothiazol-2-yl)carbox amide (1)
1H-indole-3-carboxamide (1)

First Public Date

2025 (1)
2020 (1)
2014 (1)

Classification

bacteria (1)

Study type

Comparative genomic hybridization by array (1)

Release Date

2022 (4)
2014 (2)
2024 (2)
2021 (2)
2017 (2)
2016 (2)
2011 (2)
2025 (1)
2023 (1)
2019 (1)
2012 (1)
2010 (1)
2009 (1)

Lab affiliation

Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA (1)
Head of the Curie Institute Mass Spectrometry Platform (1)

Tags

xref:PubMed:25137053 (1)
pathogen (1)
pathogen:bacterium (1)

Previous page
1 / 3
You're on page 1
page 2
page 3
Next page

Sort by:

Relevance

Page size

Klebsiella quasipneumoniae subsp. similipneumoniae strain:K87 | isolate:K87

Klebsiella quasipneumoniae subsp. similipneumoniae strain:K87 | isolate:K87 Genome sequencing

PRJNA1303087 | ENA

Identification of ubiquitination site in BCL-XL after PROTAC DT2216 treatment

The availability of a suitable lysine for PROTAC-mediated ubiquitination can also determine the degradative ability of a protein target and the selectivity of a PROTAC. PROTAC DT2216 selectively triggers ubiquitination and degradation of BCL-XL. In this study, we identify K87 is the key ubiquitinate...

ORGANISM(S): Homo sapiens (Human)

2019-10-08 | PXD015454 | Pride

Influenza A virus-triggered succinylation in lung epithelial cells

Influenza A virus (IAV) is the etiological agent of a highly contagious acute respiratory disease, which causes a considerable socioeconomic burden despite annual vaccination campaigns. Therefore, it is essential to better understand IAV-host cells interaction to help design innovative antiviral the...

ORGANISM(S): Homo sapiens (Human)

2022-03-24 | PXD018419 | Pride

Succinylation Influenza virus

Refined Candidate Region for F4ab/ac Susceptibility situated proximal to MUC13 in Pigs

A GWAS study was then performed in 52 non-adhesive and 68 strong adhesive pigs for F4ab/ac ETEC originating from 5 Belgian farms. A new refined candidate region (chr13: 144,810,100-144,993,222) for F4ac ETEC susceptibility was identified with MUC13 adjacent to the distal part of the region. All pigs...

ORGANISM(S): Sus scrofa

2014-07-31 | E-GEOD-57981 | biostudies-arrayexpress

Target molecular simulations of RecA family protein filaments.

Not available

S-EPMC3397515 | biostudies-literature

Bcl-xL acts as an inhibitor of IP₃R channels, thereby antagonizing Ca²⁺-driven apoptosis.

Not available

S-EPMC8990011 | biostudies-literature

MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta.

Not available

S-EPMC4935805 | biostudies-literature

mTORC1 phosphorylates and stabilizes LST2 to negatively regulate EGFR.